Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 11.32 USD 1.98% Market Closed
Updated: May 20, 2024

Maravai LifeSciences Holdings Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maravai LifeSciences Holdings Inc
Cost of Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Cost of Revenue
-$148.7m
CAGR 3-Years
-23%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25.3B
CAGR 3-Years
-13%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$18.2B
CAGR 3-Years
-20%
CAGR 5-Years
-20%
CAGR 10-Years
-7%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$3.3B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.7B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-10%

See Also

What is Maravai LifeSciences Holdings Inc's Cost of Revenue?
Cost of Revenue
-148.7m USD

Based on the financial report for Dec 31, 2023, Maravai LifeSciences Holdings Inc's Cost of Revenue amounts to -148.7m USD.

What is Maravai LifeSciences Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-20%

Over the last year, the Cost of Revenue growth was 12%. The average annual Cost of Revenue growth rates for Maravai LifeSciences Holdings Inc have been -23% over the past three years , -20% over the past five years .